Investors


Investor Relations

Alpha Therapy is a viable solution to treat both

Grade-II and Grade-IV Tumors

We’re at the threshold of industry transformation, as the stigmas and regulations shaping both psychedelics and mental health are challenged for the better.

The pathway for the psychedelics industry is optimistic, primed by the success of the cannabis space and international news of decriminalization. Since the first steps taken by Oregon to decriminalize psilocybin and legalize psychedelic-assisted therapy, stocks have skyrocketed for psychedelic therapy organizations in North America and the UK.

Investor

Investor
Novacurie AG GmbH HIGHLIGHTS

Why Invest


Novacurie is a diversified psychedelic research and technology company at the forefront of the mental health industry. With research into indications for Alpha Therapy research, digital therapeutics technology, and integrative partnerships, Novacurie is prepared to offer what others in the space cannot.


Learn better health outcomes, improve costs and increase productivity for your business